Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|July 31, 2024
Sleep traits and breast cancer risk: a two-sample Mendelian randomization studyJing Feng, Yixue Wen, Zhen Zhang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 25, 2019
Anlotinib Combined with S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical TrialXiyue Yang, Miao Xiang, Lidan Geng, et al.
Frontiers in Oncology|September 26, 2025
FLASH-RT for pulmonary protection: a comprehensive review of mechanisms, technological advances, and clinical translationYixue Wen, Xinlan Liu, Xiaohong Zhang, et al.
BMJ Open|October 21, 2025
Ursodeoxycholic acid for the prevention of severe radiation dermatitis: a single-arm phase I/II trial protocol in patients with breast cancer undergoing postoperative radiotherapy in ChinaXinlan Liu, Binwei Lin, Yixue Wen, et al.
Frontiers in Endocrinology|April 4, 2022
Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer DatabaseZhuowei Tang, Yuzhu Ji, Yu Min, et al.
Technology in Cancer Research & Treatment|November 30, 2023
Efficacy and Safety of Dual Anti-HER2 Blockade and Docetaxel With or Without Carboplatin as Neoadjuvant Regimen for Treatment of HER2-Positive Breast CancerBinwei Lin, Jinjia Fan, Fang Liu, et al.
Medicine|December 17, 2017
S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trialYixue Wen, Zhenhuan Zhao, Jidong Miao, et al.
The Oncologist|August 23, 2021
Anlotinib Combined with S-1 in Third- or Later-Line Stage IV Non-Small Cell Lung Cancer Treatment: A Phase II Clinical TrialMiao Xiang, Xiyue Yang, Surong Ren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 27, 2020
Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancerJie Li, Yixue Wen, Zhongzheng Xiang, et al.
Radiation Oncology (London, England)|January 24, 2018
Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysisJie Li, Youling Gong, Peng Diao, et al.
Pageof 2